PIROLA, ALESSANDRA

PIROLA, ALESSANDRA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 43 (tempo di esecuzione: 0.021 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 01 - Articolo su rivista 2020 Fontana, DilettaRamazzotti, DanieleAroldi, AndreaRedaelli, SaraMagistroni, VeraPirola, AlessandraMassimino, LucaMastini, CristinaBombelli, SilviaElli, Elena MariaFumagalli, MonicaPerego, Roberto APagni, FabioMologni, LucaPiazza, RoccoGambacorti-Passerini, Carlo +
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 01 - Articolo su rivista 2020 Piazza R.Pirola A.Gambacorti Passerini C. +
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 01 - Articolo su rivista 2019 Magistroni, VMauri, MD'Aliberti, DCrespiatico, IFontana, DSharma, NPirola, ARedaelli, SMassimino, LKhandelwal, PCitterio, SViltadi, MBombelli, SRigolio, RPerego, RGambacorti Passerini, CPiazza, R +
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 01 - Articolo su rivista 2018 Piazza, RoccoMagistroni, VeraRedaelli, SaraMauri, MarioMassimino, LucaPeronaci, MarcoPirola, AlessandraGambacorti-Passerini, Carlo +
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 01 - Articolo su rivista 2018 Mologni, LSharma, GGViltadi, MMassimino, LPurgante, SRaman, HPirola, APiazza, RGambacorti-Passerini, C +
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 01 - Articolo su rivista 2017 PIAZZA, ROCCO GIOVANNIRAMAZZOTTI, DANIELESPINELLI, ROBERTAPIROLA, ALESSANDRAMAGISTRONI, VERACORDANI, NICOLETTASHARMA, NITESH DEVINARAYANGAMBACORTI PASSERINI, CARLO +
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 01 - Articolo su rivista 2017 Piazza, RRamazzotti, DSpinelli, RPirola, AMagistroni, VCordani, NGambacorti-Passerini, C +
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 01 - Articolo su rivista 2016 REDAELLI, SARACECCON, MONICAANTOLINI, LAURARIGOLIO, ROBERTAPIROLA, ALESSANDRAPERONACI, MARCOGAMBACORTI PASSERINI, CARLOMOLOGNI, LUCA
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 01 - Articolo su rivista 2016 PIAZZA, ROCCO GIOVANNIPIROLA, ALESSANDRASPINELLI, ROBERTA +
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 02 - Intervento a convegno 2016 Piazza, RMologni, LRamazzotti, DSpinelli, RPirola, AMagistroni, VSharma, NKHANDELWAL, PRAVEENGambacorti-Passerini, C +
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 02 - Intervento a convegno 2015 Mologni, LCeccon, MFontana, DPirola, APiazza, RGambacorti-Passerini, C
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 99 - Altro 2015 Ceccon M.Mologni L.Piazza R.Pirola A.Fontana D. +
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 02 - Intervento a convegno 2015 Piazza, RPirola, ADonadoni, CFontana, DRedaelli, SFarina, FGambacorti-Passerini, C +
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 01 - Articolo su rivista 2015 CECCON, MONICAMOLOGNI, LUCAPIAZZA, ROCCO GIOVANNIPIROLA, ALESSANDRAFONTANA, DILETTAGAMBACORTI PASSERINI, CARLO +
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 02 - Intervento a convegno 2015 Piazza, RPirola, ADonadoni, CFontana, DRedaelli, SGambacorti-Passerini, C +
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 01 - Articolo su rivista 2015 PIAZZA, ROCCO GIOVANNIPIROLA, ALESSANDRAFONTANA, DILETTAMAGISTRONI, VERABORIN, LORENZA MARIAGAMBACORTI PASSERINI, CARLO +
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 02 - Intervento a convegno 2015 Redaelli, SCeccon, MPirola, APeronaci, MGambacorti-Passerini, CMologni, L
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 01 - Articolo su rivista 2015 MORI, SILVIALuciani, MREDAELLI, SARAPIROLA, ALESSANDRAPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLO +
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 01 - Articolo su rivista 2015 GAMBACORTI PASSERINI, CARLODONADONI, CARLAPIROLA, ALESSANDRAREDAELLI, SARAFONTANA, DILETTASPINELLI, ROBERTAMAGISTRONI, VERAPERONACI, MARCOPIAZZA, ROCCO GIOVANNI +
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 01 - Articolo su rivista 2015 MOLOGNI, LUCACECCON, MONICAPIROLA, ALESSANDRAPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLO +